Rekrutierende Studie = ; Fortlaufende Studie = ; Abgeschlossene Studie = ; Förderung durch ein IRDiRC-Mitglied = ; ERN-Mitglied =

Nationale klinische Studie(n)

SPANIEN

Cataluña
ESPLUGUES DE LLOBREGAT

A Pilot, Open-label, Single Arm, Multicentre Study to Explore Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Multiple Administrations of NI-0501, an Anti-interferon Gamma (Anti-IFNy) Monoclonal Antibody, in Paediatric Patients with Primary Haemophagocytic Lymphohistiocytosis which has Reactivated -ES (completed)

Hospital Sant Joan de Déu Barcelona

Servicio de Alergia e Inmunología clínica

Mehr Details

SPANIEN

Cataluña
ESPLUGUES DE LLOBREGAT

A multicentre study for the long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody - ES (completed)

Hospital Sant Joan de Déu Barcelona

Servicio de Alergia e Inmunología clínica

Mehr Details

SPANIEN

Cataluña
ESPLUGUES DE LLOBREGAT

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Mavorixafor in Patients With WHIM Syndrome With Open-Label Extension -ES

Hospital Sant Joan de Déu Barcelona

Servicio de Alergia e Inmunología clínica

Mehr Details